Dr Richard Lee is a Consultant Physician in Respiratory Medicine and Champion for Early Cancer Diagnosis at The Royal Marsden, NHS Foundation Trust. He joined The Institute of Cancer Research (ICR) in 2020 as a Team Leader for the Early Diagnosis and Detection team in the Division of Genetics and Epidemiology.
In 2002, Dr Lee completed an Undergraduate Degree in Medical Sciences at Sidney Sussex College, Cambridge. He then went on to complete his medical training in 2005 at Guy's, King's and St Thomas's School of Medicine (King's College London) before training in respiratory medicine, rotating through Guy's and St Thomas's Hospital and King's College Hospital.
Dr Lee studied EGFR TKI resistance in lung adenocarcinoma and its relevance for MET targeted therapy, for which he was awarded a PhD in Lung Cancer by Kings College London. The work was funded by the National Institute for Health Research (NIHR) and the Medical Research Council (MRC) Clinical Research Training Fellowships and he received a British Thoracic Society Young Investigator award for his research. Dr Lee went on to be awarded a Post-Graduate Certificate in Education from the King's Learning Institute, something he has a continued interest in as he teaches trainee doctors for their post-graduate examinations.
His research interest is in early cancer diagnosis with a focus on lung cancer, and leads biomarker development research for the Royal Marsden Partners Low-Dose CT Lung Cancer Case-Finding Study. Dr Lee also has an interest in artificial intelligence research, using data science to improve lung cancer care. He previously developed a Smart-Phone app for respiratory trainees called the ChestReg.
Dr Lee is actively involved in the medical community. He is the Lung Pathway Chair at the Royal Marsden Partners Cancer Alliance (North and South West London) and Joint Clinical Lead for the NHS England National Targeted Lung Health Check Pilot. He also serves on the British Thoracic Society Lung Cancer Committee and the NIHR Health Informatics Collaborative for Lung Cancer and The European Respiratory Society's College of Experts. He has also contributed to the development of Rapid Diagnosis Centres with NHS England.